Skip to content
★ Sign in to follow
JP

J P Witty

CEO
GlaxoSmithKline plc
Total declarations
4
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 14 Oct 2016 for GlaxoSmithKline plc, €1,033.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

J P Witty: trading record in brief

J P Witty appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). Over a trading history stretching from 14 July 2016 to 14 October 2016, the count stands at 4 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 14 October 2016, reports a share grant of €1,033 in GlaxoSmithKline plc. Typically, a trade is published a median of 2 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to J P Witty

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◆
    PCA of Sir Andrew Witty (Chief Executive Officer)ExecutivesGlaxoSmithKline plc
    934 GBP9FCA-NSM
    55 shares@ £16.984524.2% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20161014171320_013001980_20200330143616319_11066-4
  • ◆
    PCA of Sir Andrew Witty (Chief Executive Officer)ExecutivesGlaxoSmithKline plc
    937 GBP9FCA-NSM
    55 shares@ £17.038924.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20161014171057_013001974_20200330143616319_11065-3
  • ◆
    PCA of Sir Andrew Witty (CEO)ExecutivesGlaxoSmithKline plc
    912 GBP25FCA-NSM
    55 shares@ £16.587525.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20160718170523_012896748_20200330143558405_13596
  • ◆
    PCA of Sir Andrew Witty (CEO)ExecutivesGlaxoSmithKline plc
    915 GBP25FCA-NSM
    56 shares@ £16.3425.8% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20160718165610_012896736_20200330143558405_13588

4 of 4 declarations